Reagan Lawrence P, Hendry Robert M, Reznikov Leah R, Piroli Gerardo G, Wood Gwendolyn E, McEwen Bruce S, Grillo Claudia A
Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, 6439 Garner's Ferry Road, D40, Columbia, SC 29208, United States.
Eur J Pharmacol. 2007 Jun 22;565(1-3):68-75. doi: 10.1016/j.ejphar.2007.02.023. Epub 2007 Feb 20.
Chronic restraint stress affects hippocampal and amygdalar synaptic plasticity as determined by electrophysiological, morphological and behavioral measures, changes that are inhibited by some but not all antidepressants. The efficacy of some classes of antidepressants is proposed to involve increased phosphorylation of cAMP response element binding protein (CREB), leading to increased expression of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF). Conversely, some studies suggest that acute and chronic stress downregulate BDNF expression and activity. Accordingly, the aim of the current study was to examine total and phosphorylated CREB (pCREB), as well as BDNF mRNA and protein levels in the hippocampus and amygdala of rats subjected to chronic restraint stress in the presence and absence of the antidepressant tianeptine. In the hippocampus, chronic restraint stress increased pCREB levels without affecting BDNF mRNA or protein expression. Tianeptine administration had no effect upon these measures in the hippocampus. In the amygdala, BDNF mRNA expression was not modulated in chronic restraint stress rats given saline in spite of increased pCREB levels. Conversely, BDNF mRNA levels were increased in the amygdala of chronic restraint stress/tianeptine rats in the absence of changes in pCREB levels when compared to non-stressed controls. Amygdalar BDNF protein increased while pCREB levels decreased in tianeptine-treated rats irrespective of stress conditions. Collectively, these results demonstrate that tianeptine concomitantly decreases pCREB while increasing BDNF expression in the rat amygdala, increases in neurotrophic factor expression that may participate in the enhancement of amygdalar synaptic plasticity mediated by tianeptine.
慢性束缚应激会影响海马体和杏仁核的突触可塑性,这是通过电生理、形态学和行为学测量确定的,这些变化会被一些但并非所有的抗抑郁药所抑制。有人提出,某些类别的抗抑郁药的疗效涉及环磷酸腺苷反应元件结合蛋白(CREB)磷酸化增加,从而导致神经营养因子如脑源性神经营养因子(BDNF)的表达增加。相反,一些研究表明,急性和慢性应激会下调BDNF的表达和活性。因此,本研究的目的是检测在有或没有抗抑郁药噻奈普汀的情况下,遭受慢性束缚应激的大鼠海马体和杏仁核中总CREB和磷酸化CREB(pCREB)以及BDNF mRNA和蛋白水平。在海马体中,慢性束缚应激增加了pCREB水平,但不影响BDNF mRNA或蛋白表达。给予噻奈普汀对海马体中的这些指标没有影响。在杏仁核中,尽管pCREB水平升高,但给予生理盐水的慢性束缚应激大鼠的BDNF mRNA表达未受到调节。相反,与非应激对照组相比,慢性束缚应激/噻奈普汀大鼠杏仁核中的BDNF mRNA水平在pCREB水平未发生变化的情况下升高。无论应激条件如何,噻奈普汀治疗的大鼠杏仁核中的BDNF蛋白增加而pCREB水平降低。总体而言,这些结果表明,噻奈普汀在大鼠杏仁核中同时降低pCREB,同时增加BDNF表达,神经营养因子表达的增加可能参与了噻奈普汀介导的杏仁核突触可塑性的增强。